Panagiotopoulos Vasileios, Athinodorou Ioannis Panagiotis, Kolios Kyprianos, Kattou Constantinos, Grzeczinski Andreas, Theofanopoulos Andreas, Messinis Lambros, Constantoyannis Constantine, Zampakis Petros
Department of Neurosurgery, General University Hospital of Patras, Patras, Greece.
Department of Neuropsychology, General University Hospital of Patras, Patras, Greece.
J Cerebrovasc Endovasc Neurosurg. 2025 Mar;27(1):1-18. doi: 10.7461/jcen.2024.E2024.05.004. Epub 2024 Dec 17.
Endovascular treatment of intracranial aneurysms (IAs) provides less invasiveness and lower morbidity than microsurgical clipping, albeit with a long-term recurrence rate estimated at 20%. We present our single-center experience and a literature review concerning surgical clipping of recurrent previously coiled aneurysms.
Retrospective analysis of nine (9) patients' data and final clinical/angiographic outcomes, who underwent surgical clipping of IAs in our center following initial endovascular treatment, over a 12-year period (2010-2022). Regarding the literature review, data were extracted from 48 studies including 969 patients with 976 aneurysms.
9 patients (5 males - 4 females) were included in the study with a mean age of 49 years. Subarachnoid hemorrhage was the initial presentation in 78% of patients. Aneurysms' most common location was the middle cerebral artery bifurcation (5/9) followed by the anterior communicating artery (3/9) and the internal carotid artery bifurcation (1/9). Indications for surgery were coil loosening, coil compaction, sac regrowth, and residual neck. Procedure-related morbidity and mortality were zero whereas complete aneurysm occlusion was achieved after surgical clipping in all cases (100%). All patients had minimal symptoms or were asymptomatic (mRS 0-1) at the final follow-up.
Surgical clipping seems a feasible and safe technique for selected cases of recurrent previously coiled intracranial aneurysms. A universally accepted recurrence classification system and a guideline template for the management of such cases are needed.
颅内动脉瘤(IAs)的血管内治疗比显微外科夹闭术侵入性更小、发病率更低,尽管其长期复发率估计为20%。我们介绍了我们的单中心经验以及关于对先前已栓塞的复发性动脉瘤进行手术夹闭的文献综述。
回顾性分析了在12年期间(2010 - 2022年),在我们中心接受初次血管内治疗后又进行IAs手术夹闭的9例患者的数据以及最终的临床/血管造影结果。关于文献综述,数据提取自48项研究,包括969例患者的976个动脉瘤。
9例患者(5例男性 - 4例女性)纳入研究,平均年龄为49岁。78%的患者最初表现为蛛网膜下腔出血。动脉瘤最常见的位置是大脑中动脉分叉处(5/9),其次是前交通动脉(3/9)和颈内动脉分叉处(1/9)。手术指征为弹簧圈松动、弹簧圈压缩、瘤囊再生长和残余瘤颈。与手术相关的发病率和死亡率为零,所有病例(100%)在手术夹闭后均实现了动脉瘤完全闭塞。所有患者在最后一次随访时症状轻微或无症状(改良Rankin量表评分0 - 1分)。
对于选定的先前已栓塞的复发性颅内动脉瘤病例,手术夹闭似乎是一种可行且安全的技术。需要一个普遍接受的复发分类系统和此类病例管理的指南模板。